Welcome to FIT Biotech’s investor pages!

These pages give you background about FIT Biotech as an investment.

Our strategy focuses on licensing our patented GTU® (Gene Transport Unit) technology to partners for medical applications, in particular for applications with high commercial potential targeted at existing large markets or markets with a need for more efficient, safer and less costly treatments.